Published in Am J Hum Genet on August 01, 1991
Genetic Epidemiology of Coronary Heart Disease | NCT00005209
Haplotype structure and population genetic inferences from nucleotide-sequence variation in human lipoprotein lipase. Am J Hum Genet (1998) 7.56
Linkage disequilibrium predicts physical distance in the adenomatous polyposis coli region. Am J Hum Genet (1994) 2.65
Linkage disequilibrium in the neurofibromatosis 1 (NF1) region: implications for gene mapping. Am J Hum Genet (1993) 1.83
The gender-specific apolipoprotein E genotype influence on the distribution of plasma lipids and apolipoproteins in the population of Rochester, Minnesota. II. Regression relationships with concomitants. Am J Hum Genet (1992) 1.16
Association of the TNF-alpha-308 (G-->A) polymorphism with self-reported history of childhood asthma. Hum Genet (2000) 0.98
Genetic structure and the search for genotype-phenotype relationships: an example from disequilibrium in the Apo B gene region. Genetics (1991) 0.95
Polymorphic haplotypes and recombination rates at the LDL receptor gene locus in subjects with and without familial hypercholesterolemia who are from different populations. Am J Hum Genet (1993) 0.88
Apolipoprotein C3 polymorphisms, cognitive function and diabetes in Caribbean origin Hispanics. PLoS One (2009) 0.77
No adjustments are needed for multiple comparisons. Epidemiology (1990) 23.80
High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med (1977) 15.39
Estimation of linkage disequilibrium in randomly mating populations. Heredity (Edinb) (1974) 7.24
A general cardiovascular risk profile: the Framingham Study. Am J Cardiol (1976) 5.10
Apolipoprotein genetic variation and human disease. Physiol Rev (1988) 3.29
The detection of linkage disequilibrium between closely linked markers: RFLPs at the AI-CIII apolipoprotein genes. Am J Hum Genet (1988) 2.85
A cladistic analysis of phenotype associations with haplotypes inferred from restriction endonuclease mapping. II. The analysis of natural populations. Genetics (1988) 2.68
A protein cofactor of lecithin:cholesterol acyltransferase. Biochem Biophys Res Commun (1972) 2.37
Analysis of multilocus genetic systems in Tecumseh, Michigan. II. Consideration of the correlation between nonalleles in gametes. Am J Hum Genet (1972) 2.32
DNA polymorphism adjacent to human apoprotein A-1 gene: relation to hypertriglyceridaemia. Lancet (1983) 2.28
Deoxyribonucleic acid polymorphism in the apolipoprotein A-1-C-III gene cluster. Association with hypertriglyceridemia. J Clin Invest (1985) 1.73
Introduction to the plasma lipoproteins. Methods Enzymol (1986) 1.71
Apolipoprotein A-I gene polymorphism associated with premature coronary artery disease and familial hypoalphalipoproteinemia. N Engl J Med (1986) 1.70
Linkage of human apolipoproteins A-I and C-III genes. Nature (1983) 1.66
A study of DNA polymorphisms around the human apolipoprotein AI gene in hyperlipidaemic and normal individuals. Clin Genet (1985) 1.62
Apolipoprotein A-I as a marker of angiographically assessed coronary-artery disease. N Engl J Med (1983) 1.56
Linkage disequilibria between pairs of loci within a highly polymorphic region of chromosome 2Q. Am J Hum Genet (1986) 1.50
Lipoprotein apoprotein metabolism. J Lipid Res (1978) 1.48
Genetic factors affecting blood lipoproteins: the candidate gene approach. J Lipid Res (1988) 1.38
The effects of subfractions of high density lipoprotein on cholesterol efflux from cultured fibroblasts. Regulation of low density lipoprotein receptor activity. J Biol Chem (1981) 1.36
DNA polymorphism haplotypes of the human apolipoprotein APOA1-APOC3-APOA4 gene cluster. Hum Genet (1988) 1.32
DNA inversion within the apolipoproteins AI/CIII/AIV-encoding gene cluster of certain patients with premature atherosclerosis. Proc Natl Acad Sci U S A (1987) 1.28
DNA polymorphism and the study of disease associations. Hum Genet (1988) 1.24
A DNA insertion in the apolipoprotein A-I gene of patients with premature atherosclerosis. Nature (1983) 1.24
Linkage disequilibrium between DNA markers at the low-density lipoprotein receptor gene. Genet Epidemiol (1990) 1.15
Apolipoproteins and coronary artery disease. Mayo Clin Proc (1986) 1.11
Polymorphisms in the apolipoprotein AI-CIII gene complex. Mol Biol Med (1986) 1.07
Human apolipoprotein A-I and C-III genes reside in the p11----q13 region of chromosome 11. Biochem Biophys Res Commun (1984) 1.06
Genetic polymorphisms of apolipoprotein C-III and insulin in survivors of myocardial infarction. Lancet (1985) 1.04
DNA polymorphisms in the apolipoprotein C-III and insulin genes and atherosclerosis. Atherosclerosis (1985) 1.03
Structure, evolution, and tissue-specific synthesis of human apolipoprotein AIV. Biochemistry (1986) 0.98
Genetics of coronary heart disease. Prog Med Genet (1983) 0.98
DNA polymorphic patterns and haplotype arrangements of the apo A-1, apo C-III, apo A-IV gene cluster in different ethnic groups. Hum Genet (1987) 0.97
Genetics of atherosclerosis. Annu Rev Genet (1990) 0.97
Genetic and cultural inheritance of serum lipids, low and high density lipoprotein cholesterol and serum apolipoproteins A-I, A-II and B. Atherosclerosis (1986) 0.94
Effects of the apolipoprotein E polymorphism on levels of lipids, lipoproteins, and apolipoproteins among Mexican-Americans in Starr County, Texas. Arterioscler Thromb (1991) 0.89
Linkage disequilibrium analyses and restriction mapping of four RFLPs at the pro alpha 2(I) collagen locus: lack of correlation between linkage disequilibrium and physical distance. Hum Genet (1988) 0.89
Apolipoprotein A-I gene polymorphisms: frequency in patients with coronary artery disease and healthy controls and association with serum apo A-I and HDL-cholesterol concentration. Atherosclerosis (1989) 0.87
DNA polymorphisms of the apolipoprotein AII and AI-CIII-AIV genes: a study in men selected for differences in high-density-lipoprotein cholesterol concentration. Am J Hum Genet (1988) 0.86
DNA polymorphisms around the apo AI gene in normal and hyperlipidaemic individuals selected for a twin study. Clin Genet (1986) 0.86
Genetic variation in the apolipoprotein AI-CIII-AIV gene cluster and coronary heart disease. Atherosclerosis (1988) 0.86
A PvuII polymorphism in the 5' flanking region of the apolipoprotein AIV gene: its use to study genetic variation determining serum lipid and apolipoprotein concentration. Hum Genet (1988) 0.84
DNA polymorphic sites in the human ApoAI-CIII-AIV cluster: Taq I and Ava I. Nucleic Acids Res (1986) 0.83
The two apolipoprotein loci apo A-I and apo A-IV are closely linked in man. Hum Genet (1984) 0.83
Haplotypes of the human apoprotein AI-CIII-AIV gene cluster in coronary atherosclerosis. Hum Genet (1986) 0.80
Genetics and public health in the 1990s. Annu Rev Public Health (1990) 0.80
PvuII polymorphic site upstream to the human ApoCIII gene. Nucleic Acids Res (1986) 0.79
Study of DNA polymorphisms of the apolipoprotein AI-CIII-AIV gene cluster in patients with peripheral arterial disease. Clin Sci (Lond) (1989) 0.78
Deoxyribonucleic acid (DNA) polymorphism in the apolipoprotein AI gene: a study in a Japanese population. Jpn J Med (1988) 0.78
Gene polymorphisms and variability of human apolipoproteins. Annu Rev Nutr (1989) 0.78
Lipid markers for atherosclerosis. Am J Cardiol (1986) 0.77
Linkage disequilibrium between two restriction sites in the COL2A1 gene. Am J Hum Genet (1990) 0.77
Genetic marker in apolipoprotein AI/CIII gene complex associated with hypercholesterolaemia. Lancet (1986) 0.77
DNA sequence diversity in a 9.7-kb region of the human lipoprotein lipase gene. Nat Genet (1998) 11.70
A cladistic analysis of phenotypic associations with haplotypes inferred from restriction endonuclease mapping and DNA sequence data. III. Cladogram estimation. Genetics (1992) 10.09
Haplotype structure and population genetic inferences from nucleotide-sequence variation in human lipoprotein lipase. Am J Hum Genet (1998) 7.56
A combinatorial partitioning method to identify multilocus genotypic partitions that predict quantitative trait variation. Genome Res (2001) 6.06
Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis (1988) 6.01
The use of measured genotype information in the analysis of quantitative phenotypes in man. I. Models and analytical methods. Ann Hum Genet (1986) 5.02
Apolipoprotein E polymorphism and Alzheimer's disease. Lancet (1993) 4.47
Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation. Am J Hum Genet (1985) 3.81
Recombinational and mutational hotspots within the human lipoprotein lipase gene. Am J Hum Genet (2000) 2.83
The unit of selection in Drosophila mercatorum. I. The interation of selection and meiosis in parthenogenetic strains. Genetics (1976) 2.71
A cladistic analysis of phenotype associations with haplotypes inferred from restriction endonuclease mapping. II. The analysis of natural populations. Genetics (1988) 2.68
Apolipoprotein E variation at the sequence haplotype level: implications for the origin and maintenance of a major human polymorphism. Am J Hum Genet (2000) 2.62
The population genetics of parthenogenetic strains of Drosophila mercatorium. II The capacity for parthenogenesis in a natural, bisexual population. Genetics (1976) 2.56
Sequence diversity and large-scale typing of SNPs in the human apolipoprotein E gene. Genome Res (2000) 2.53
A cladistic analysis of phenotypic associations with haplotypes inferred from restriction endonuclease mapping. IV. Nested analyses with cladogram uncertainty and recombination. Genetics (1993) 2.52
Analysis of multilocus genetic systems in Tecumseh, Michigan. II. Consideration of the correlation between nonalleles in gametes. Am J Hum Genet (1972) 2.32
A model for analysis of population structure. Genetics (1974) 2.02
Acute influence of smoking on platelet behaviour, endothelium and plasma lipids and normalization by aspirin. Atherosclerosis (1992) 2.01
Deletion in the gene for the low-density-lipoprotein receptor in a majority of French Canadians with familial hypercholesterolemia. N Engl J Med (1987) 1.96
Familial defective apolipoprotein B-100: a mutation of apolipoprotein B that causes hypercholesterolemia. J Lipid Res (1990) 1.90
Modulation of plasma triglyceride levels by apoE phenotype: a meta-analysis. J Lipid Res (1992) 1.83
Common low-density lipoprotein receptor mutations in the French Canadian population. J Clin Invest (1990) 1.82
Genome-wide linkage analyses of systolic blood pressure using highly discordant siblings. Circulation (1999) 1.81
Homozygous familial hypercholesterolemia among French Canadians in Québec Province. Arteriosclerosis (1989) 1.68
Plasma total homocysteine in healthy subjects: sex-specific relation with biological traits. Am J Clin Nutr (1996) 1.67
Variation in the region of the angiotensin-converting enzyme gene influences interindividual differences in blood pressure levels in young white males. Circulation (1998) 1.65
Bias of the contribution of single-locus effects to the variance of a quantitative trait. Am J Hum Genet (1986) 1.65
Cladistic structure within the human Lipoprotein lipase gene and its implications for phenotypic association studies. Genetics (2000) 1.64
A common DNA polymorphism of the low-density lipoprotein (LDL) receptor gene and its use in diagnosis. Lancet (1985) 1.64
A study of DNA polymorphisms around the human apolipoprotein AI gene in hyperlipidaemic and normal individuals. Clin Genet (1985) 1.62
Some genetic programs to supplement self-instruction in FORTRAN. Am J Hum Genet (1967) 1.60
The interaction of cholesterol absorption and cholesterol synthesis in man. J Lipid Res (1969) 1.56
Molecular mapping of Alzheimer-type dementia in Down's syndrome. Ann Neurol (1998) 1.50
Heterotrisomy, a significant contributing factor to ventricular septal defect associated with Down syndrome? Hum Genet (2000) 1.47
Studies on genetic selection in a completely ascertained caucasian population. II. Family analyses of 11 blood group systems. Am J Hum Genet (1971) 1.46
Studies on genetic selection in a completely ascertained caucasian population. I. Frequencies, age and sex effects, and phenotype associations for 12 blood group systems. Am J Hum Genet (1971) 1.44
Analysis of genetic and environmental sources of variation in serum cholesterol in Tecumseh, Michigan. III. Identification of genetic effects using 12 polymorphic genetic blood marker systems. Am J Hum Genet (1976) 1.42
Studies of isozyme patterns in nullisomic-tetrasomic combinations of hexaploid wheat. Proc Natl Acad Sci U S A (1969) 1.38
Positional genomic analysis identifies the beta(2)-adrenergic receptor gene as a susceptibility locus for human hypertension. Circulation (2000) 1.36
Apolipoprotein E polymorphism predicts death from coronary heart disease in a longitudinal study of elderly Finnish men. Circulation (1995) 1.35
Apolipoprotein B gene variants are involved in the determination of serum cholesterol levels: a study in normo- and hyperlipidaemic individuals. Atherosclerosis (1987) 1.32
Efficacy and safety of a new HMG-CoA reductase inhibitor, atorvastatin, in patients with hypertriglyceridemia. JAMA (1996) 1.29
Distribution of sodium-lithium countertransport and blood pressure in Caucasians five to eighty-nine years of age. Hypertension (1989) 1.28
Usefulness of probucol in treating primary hypercholesterolemia. Can Med Assoc J (1980) 1.27
The gender-specific apolipoprotein E genotype influence on the distribution of lipids and apolipoproteins in the population of Rochester, MN. I. Pleiotropic effects on means and variances. Am J Hum Genet (1991) 1.25
Plasma kinetics of apoC-III and apoE in normolipidemic and hypertriglyceridemic subjects. J Lipid Res (2000) 1.24
The genetic linkage relations of adenylate kinase: further data on the ABO-AK linkage group. Am J Hum Genet (1969) 1.23
Effects of polymorphisms in apolipoproteins E, A-IV, and H on quantitative traits related to risk for cardiovascular disease. Arterioscler Thromb (1991) 1.22
Analysis of genetic and environmental sources of variation in serum cholesterol in Tecumseh, Michigan. V. Variance components estimated from pedigrees. Ann Hum Genet (1979) 1.21
Treatment outcome of tacrine therapy depends on apolipoprotein genotype and gender of the subjects with Alzheimer's disease. Neurology (1998) 1.19
Apolipoprotein E phenotyping with a single gel method: application to the study of informative matings. J Lipid Res (1983) 1.17
The gender-specific apolipoprotein E genotype influence on the distribution of plasma lipids and apolipoproteins in the population of Rochester, Minnesota. II. Regression relationships with concomitants. Am J Hum Genet (1992) 1.16
Diet and probucol in lowering cholesterol concentrations. Additive effects on plasma cholesterol concentrations in patients with familial type ii hyperlipoproteinemia. Arch Intern Med (1977) 1.14
Apolipoprotein E and beta-amyloid levels in the hippocampus and frontal cortex of Alzheimer's disease subjects are disease-related and apolipoprotein E genotype dependent. Brain Res (1999) 1.12
Familial aggregation of blood pressure and weight in adoptive families. II. Estimation of the relative contributions of genetic and common environmental factors to blood pressure correlations between family members. Am J Epidemiol (1979) 1.11
The genetic determination of plasma apolipoprotein A-I levels measured by radioimmunoassay: a study of high-risk pedigrees. Am J Hum Genet (1986) 1.11
Impact of apoE deficiency on oxidative insults and antioxidant levels in the brain. Brain Res Mol Brain Res (2001) 1.10
Oxidative insults are associated with apolipoprotein E genotype in Alzheimer's disease brain. Neurobiol Dis (2000) 1.09
Linkage and association of adrenergic and dopamine receptor genes in the distal portion of the long arm of chromosome 5 with systolic blood pressure variation. Hum Mol Genet (1998) 1.09
Identification of a deletion in the low density lipoprotein (LDL) receptor gene in a patient with familial hypercholesterolaemia. Hum Genet (1985) 1.08
Analysis of genetic and environmental sources of variation in serum cholesterol in Tecumseh, Michigan. IV. Separation of polygene from common environment effects. Am J Hum Genet (1978) 1.08
The low density lipoprotein receptor is not required for normal catabolism of Lp(a) in humans. J Clin Invest (1995) 1.07
Genotype-environment interaction: apolipoprotein E (ApoE) gene effects and age as an index of time and spatial context in the human. Genetics (1996) 1.06
Oxidative stress leads to cholesterol accumulation in vascular smooth muscle cells. Free Radic Biol Med (1999) 1.05
The genetics of the Lp antigen. II. A family study and proposed models of genetic control. Ann Hum Genet (1974) 1.04
Genetic linkage relations of the loci for 6-phosphogluconate dehydrogenase and adenosine deaminase in man. Am J Hum Genet (1970) 1.03
Inherited biochemical variation in Drosophila melanogaster: noise or signal? I. Single-locus analysis. Genetics (1973) 1.02
Apolipoprotein E polymorphism and atherosclerosis: insight from a study in octogenarians. Trans Am Clin Climatol Assoc (1988) 1.02
Simvastatin inhibits the oxidation of low-density lipoproteins by activated human monocyte-derived macrophages. Biochim Biophys Acta (1993) 1.01
Isolation and characterization of apolipoprotein B-48 and B-100 very low density lipoproteins from type III hyperlipoproteinemic subjects. J Clin Invest (1984) 1.00
Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians. Can J Cardiol (1997) 1.00
Plasma lipoprotein distribution of apoC-III in normolipidemic and hypertriglyceridemic subjects: comparison of the apoC-III to apoE ratio in different lipoprotein fractions. J Lipid Res (1997) 0.99
Coronary artery disease in heterozygous familial hypercholesterolemia patients with the same LDL receptor gene mutation. Circulation (1995) 0.99
Analysis of the distribution of erythrocyte sodium lithium countertransport in a sample representative of the general population. Genet Epidemiol (1986) 0.98
Association of the TNF-alpha-308 (G-->A) polymorphism with self-reported history of childhood asthma. Hum Genet (2000) 0.98
Evidence that a single gene with gender- and age-dependent effects influences systolic blood pressure determination in a population-based sample. Am J Hum Genet (1991) 0.97
Influences of common variants of apolipoprotein E on measures of lipid metabolism in a sample selected for health. Arterioscler Thromb (1991) 0.97
Eruptive and tubero-eruptive xanthomas of the skin arising on sites of prior injury. Two case reports. JAMA (1988) 0.96
Current and future treatment of hyperlipidemia: the role of statins. Am J Cardiol (1998) 0.95
Heterogeneity of sickle-cell anemia based on a profile of hematological variables. Am J Hum Genet (1983) 0.95
Genetic structure and the search for genotype-phenotype relationships: an example from disequilibrium in the Apo B gene region. Genetics (1991) 0.95
Multivariate models for human genetic analysis: aggregation, coaggregation, and tracking of systolic blood pressure and weight. Am J Hum Genet (1983) 0.95
Expression of the developmental and oncogenic PAX2 gene in human prostate cancer. J Urol (2001) 0.95
Meiotic crossing-over in nondisjoined chromosomes of children with trisomy 21 and a congenital heart defect. Am J Hum Genet (1993) 0.95
Analysis of multilocus genetic systems in Tecumseh, Michigan. I. Definition of the data set and tests for goodness-of-fit to expectations based on gene, gamete, and single-locus phenotype frequencies. Am J Hum Genet (1972) 0.95
An ecological study of association between coronary heart disease mortality rates in men and the relative frequencies of common allelic variations in the gene coding for apolipoprotein E. Hum Genet (1998) 0.94
Beta-amyloid peptides increase the binding and internalization of apolipoprotein E to hippocampal neurons. J Neurochem (1998) 0.94
Long-term efficacy and tolerability of simvastatin in a large cohort of elderly hypercholesterolemic patients. Atherosclerosis (1995) 0.94
Genome-wide linkage analysis reveals evidence of multiple regions that influence variation in plasma lipid and apolipoprotein levels associated with risk of coronary heart disease. Arterioscler Thromb Vasc Biol (2001) 0.94
H-2 and non-H-2 determined strain variation in palatal shelf and tongue adenosine 3':5' cyclic monophosphate: a possible role in the etiology of steroid-induced cleft palate. J Immunogenet (1979) 0.94